Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades
Digital intelligence specialist Cellebrite DI Ltd. (Nasdaq: CLBT) is jumping on Thursday, November 13, 2025, after posting stronger‑than‑expected third‑quarter results and lifting its 2025 outlook, prompting multiple bullish calls from Wall Street. CLBT stock jumps as investors digest Q3 beat Cellebrite shares are rallying sharply in today’s session. As of mid‑afternoon trading on November 13, CLBT is changing hands around $19.80, up roughly 24% from the pre‑earnings close, on heavy volume. Benzinga Pre‑market, the stock was already up more than 20%, after the company reported better‑than‑expected Q3 2025 numbers and raised its full‑year guidance, drawing trader attention to the name.